Etanercept
CAS 185243-69-0 3 FDA-DMF suppliersBiologic
Overview
Etanercept is a biopharmaceutical that inhibits tumor necrosis factor (TNF), which is used to treat autoimmune diseases such as rheumatoid arthritis and psoriasis. It is a fusion protein produced by recombinant DNA technology.
Therapeutic areas
RheumatologyDermatologyGastroenterology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.